CD4 and rheumatoid arthritis: We showed that despite using well-validated markers, the proportion of the total Treg cell population, such as CD25+Foxp3+ and CD25+Foxp3+ CD127−/low, in CD4+ T cells did not show any significant change in the peripheral blood of RA patients.